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Malignant Lymphomas in Transplantation Patients 
By I. PENN, W. HAMMOND, L. BRETISCHNEIDER, AND T. E. STARZL 
IT IS KNOWN from animal studies 1 that 
malignant tumors may develop in certain 
conditions characterized by disturbances of 
the host's immune defenses. The same is 
apparently true in man. For example, pa-
tients suffering from agammaglobulinemia, 
hypogammaglobulinemia and deficiencies 
of cell mediated immunity have a high 
incidence of malignancy involving either 
lymphoid or other tissues.2,4 An increased 
frequency of neoplasms has also been ob-
served in a variety of "autoimmune" dis-
orders.3 
A prerequisite for success in clinical or-
gan transplantation is the iatrogenic alter-
ation of the host immune apparatus. A co-
incidental effect might be predicted to be 
an increased incidence of neoplasia. This 
possibility is supported in the present com-
munication, which describes the develop-
ment of malignant lymphoid tumors in 5 
recipients of renal homo grafts, treated with 
differing immunosuppressive regimens at 3 
widely separated transplantation centers 
(Table 1). A brief summary of the cases 
has already been reported.5 The occurrence 
of these tumors indicates that malignant 
disease may be a significant hazard of organ 
transplantation and long continued immu-
nosuppressive therapy. 
CLINICAL MATERIAL 
Case 1 (Denver)-Prior to transplantation in 
May 1967, the patient complained of headaches, 
dizziness, blurred vision, nausea and vomiting. He 
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also suffered 2 generalized epileptiform seizures. 
Neurologic examination was negative and his symp-
toms were attributed to severe hypertension. 
Renal homotransplantation was performed in 
May 1967. Immunosuppression was with azathio-
prine, prednisone, and horse antilymphocyte globu-
lin (ALG). Two months after operation, he had a 
generalized seizure and remained confused and in-
coherent for several days. At that time he was being 
treated for threatened rejection of the homograft, 
was hypertensive, and was observed to be exceed-
ing his restricted fluid allowance. Serum chemis-
tries showed evidence of marked hemodilution. He 
was considered to be suffering from water intoxi-
cation. His condition promptly improved on a 
regimen of fluid restriction and administration of 
sodium chloride and potassium supplements. There 
were no further neurologic symptoms until 9 days 
before the diagnosis of reticulum cell sarcoma was 
made by craniotomy. The very extensive tumor of 
the brain (Figure 1) was the cause of the patient's 
death. Renal function was normal in the last 
months of life. 
In this case, the possibility could not be ex-
cluded that the tumor was present at the time of 
transplantation and was the cause of his earlier 
neurologic symptoms. 
Case 2 (Denver)-The patient was treated with 
continuous azathioprine and prednisone, and with 
actinomycin C and local homograft irradiation for 
threatened rejection. He had persistent hyper-
calcemia following his renal transplant operation. 
A parathyroidectomy performed on March 29, 
1966. The thyroid gland was found to be normal 
at this operation, but at autopsy on December 6, 
1967 was found to be enlarged and almost com-
pletely replaced by tumor. Renal function was 
subnormal, but adequate, throughout life. 
Death occurred 6 days after emergency vagot. 
omy and gastrectomy performed to control massive 
upper gastrointestinal bleeding. The resected por-
tion of stomach contained several ulcers, in the 
bases of which were small collections of tumor 
cells that were strikingly similar to those found in 
the brain of the first patient. At autopsy wide-
spread tumor was found (Figure 2). 
Case 3 (Denver)-Immunosuppression was with 
azathioprine, prednisone and a 7 week course of 
heterologous ALG. Seven months after renal homo-
transplantation the patient developed a rapidly 
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Fig. I.-Case 1. Tumor nodules (arrows) in the left occipital lobe and cerebellum. The 
flattened gyri reflect increased intracranial pressure caused by the tumor. Tnsert- The large, 
uniform cells with indistinct cytoplasm and round to oval nuclei are characteristic of reticulum 
cell sarcoma (X350). 
progressing left hemiparesis. A lesion in the right 
anterior and mid-thalamic areas was identified with 
pneumoencephalography and biopsied with a stere-
otaxic technique. The histologic findings were con-
sistent with a tumor of lymphoid origin, possibly a 
plasmacytoma. Extensive special diagnostic studies 
revealed no evidence of multiple myeloma or any 
other site of tumor. 
Radiotherapy to the brain (5650 rads) combined' 
with reduction in the dosage of prednisone and 
azathioprine (Figure 3) resulted in striking im-
provement in the patient's neurologic condition. 
She is well with moderate but stable residual 
hemiparesis at the present time. 
Case 4 (Minneapolis, Dr. Claude Hitchcock)-
Renal homotransplantation was performed under 
treatment with azathioprine and prednisone. Ten 
months later, the liver became enlarged and was 
proved by biopsy to contain a lymphosarcoma. 
Two courses of radioactive cobalt therapy, each of 
2,500 rads, were given to the liver area. Thirteen 
months after transplantation the patient became 
jaundiced and developed ascites. Death in hepatic 
coma occurred one month later. Autopsy examina-
tion revealed tumor nodules in the liver, varying 
from 2 to 10 em in diameter. Similar tumor in-
volvement was found in the left cerebellar cortex. 
The bone marrow was Riled with lymphosarcoma. 
Case 5 (Edinburgh, Mr. M.F.A. Woodruff)-A 
patient being treated with azathioprine and pred-
nisone developed right-sided pleurisy 518 days 
after renal homotransplantation. About fg~ months 
earlier, a 10 day course of horse ALG had been 
given for the indication of late rejection. A locu-
lated effusion between the right upper lobe and 
mediastinum was seen in the chest x-ray. This 
slowly diminished in size when antibiotics were 
given and could no longer be easily seen OF~ 
months later. A chest x-ray 725 days post-trans-
plantation showed a recurrence and extension of 
the aforementioned radiographic abnormalities. 
Operation revealed a reticulum cell sarcoma affect-
ing th e mediastinal lymph nodes and ulcerating 
through the pleura. The patient died 760 days after 
Fig OK-C:Kls~ 2. A.-This 5 cm nodule was one of several found in the liver. B.-Malig-
nant reticulum cclls have massively in6ltrated the thyroid, separating the follicles widely (X80). 
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Fig, 3.-The course of a patient (Case 3) who developed a plasmacytoma in the di-
encephalon more than 7 months after renal homotransplantation from her father. The tumor 
w as inaciiated and the doses of both azathioprine and prednisone were drastically reduced. 
The neurologic deficit was partially reversed and has not progressed subsequently. Renal 
function has remainecl good. 
llO 
transplantation. The kidney functioned throughout 
life. 
OTHER PATHOLOGIC STUDIES 
The lymphoid tissues from autopsy ex-
amination were reviewed in 24 recipients 
of kidney or liver homo grafts who died 
without previous evidence of malignancy. 
In 13 of these cases, immunosuppressive 
therapy had been with azathioprine and 
prednisone and in the other ll, ALG had 
also been administered. In no case was 
there any abnormal proliferation of lym-
phoid tissue. In fact, the lymphoid tissues 
were grossly depleted, more so in the thy-
mus and gastrointestinal tract than in the 
lymph nodes. In the lymph nodes, lym-
phoid follicles were small and poorly 
formed and germinal centers were ex-
tremely rare. There was a proportionately 
greater reduction in small lymphocytes 
than in plasma cells. 
DISCUSSION 
In these patients, the probability is 
strong that the neoplasms began de novo 
at some time after the transplantation. 
Only in Case 1 was there any suggestion 
that the tumor might have antedated the 
original operation. Moreover, there was no 
evidence that the tumors were trans-
planted from the donors. All 5 kidneys 
were obtained from living related volun-
teers who have remained in good health 
from one to 4 years after their nephrec-
tomies. 
A number of the conditions present in 
the human recipients of renal homo grafts 
herein reported have been shown in ex-
perimental animals to be capable of induc-
ing or influencing oncogenesis under the 
appropriate circumstances. These include 
the depression of immunologic reactivity 
by thymectomy,6.8 antilymphocyte serum,7.8 
and azathioprine 9 or by the provision of 
chronic antigenic stimulation.1.1o.1l 
In the clinical situation, the relative con-
tribution of any single factor is impossible 
to assess. All 5 of the patients received 
immunosuppressive therapy with azathio-
prine and prednisone, 4 underwent sple-
nectomy, one had a thymectomy and 3 re-
ceived heterologous ALG. Beside therapy 
with azathioprine and prednisone, the 
common feature in all cases was the con-
tinuous presence of antigen in the form of 
a homograft. Four of the 5 patients had 
severe problems with rejection and re-
ceived large doses of immunosuppressive 
agents to control this reaction. 
It has been suggested that the increased 
incidence of malignancy which follows im-
munologic depression is due to a loss of 
the surveillance mechanism by which mu-
tant cells are repudiated as "non-self." 3.12 
This point of view has been strongly sup-
ported by the ease with which neoplasms 
have been accidentally transplanted from 
cadaveric renal donors who died of can-
cer,13 and by the subsequent disappearance 
of a transplanted malignant growth in at 
least one case after immunosuppression 
had been discontinued.14 
While probably germane to the pres-
ently reported cases, the foregoing se-
quence of events does not explain the pe-
culiar predisposition to the development of 
lympho-reticular tumors. It is conceivable 
that chronic antigenic stimulation was an 
added pathogenetic determinant, even 
though the lymphoid tissues in our 3 pa-
tients (Cases 1-3), as well as in 24 others 
who died without neoplasia, had variable 
involution. 
It remains to be determined to what ex-
tent the appearance of neoplastic growth 
will be a complication of clinical organ 
transplantation. At the moment, it appears 
that the incidence will be low enough so 
that the usefulness of such procedures will 
not be vitiated. In the meanwhile, it is im-
portant to be alert to this diagnostic pos-
sibility since only in this way can effective 
therapy be instituted as was accomplished 
in Case 3. 
So far the predominant risk after trans-
plantation has seemed to be the appear-
ance of mesenchymal tumors, although 
there have also been 2 reported epithelial 
malignancies which developed anew in re-
cipients of renal homografts. One was a 
fatal dysgerminoma of the ovary in Good's 
patient.3 The other was a squamous cell 
carcinoma of the ear in one of our patients 
who was included in Hume's inter-institu-
tional compilation.13 In the latter case the 
lesion of the ear appeared 2 years after 
renal homotransplantation and was cured 
by a radical excision. The patient died of 
a perforated sigmoid diverticulitis 2 years 
later. 
Further knowledge about the general ef-
fect of transplantation and immunosup-
pression on tumor growth will have an im-
portant bearing on the advisability of or-
gan replacement for the treatment of pri-
mary malignancies of vital structures such 
III 
as the kidney, liver, and lung. In Hume's 
report 13 there were several examples of 
renal homotransplantation in patients with 
Wilm's tumor or hypernephroma. There was 
only one example of a recurrence. In our 
series of orthotopic liver transplantations for 
hepatoma, there have been 3 recipients 
with survival of 5 months or longer. One of 
these patients died of widespread metas-
tases after fP~~ months, another has radio-
graphic evidence of early pulmonary metas-
tases at 5 months, and the third is free of 
detectable tumor after 6 months.15 
SUMMARY 
Malignant lymphomas developed in 5 
renal homograft recipients treated at 3 
widely separated transplantation centers. 
The development of these tumors appears 
to be an indirect complication of organ 
transplantation and/ or the meamres taken 
to prevent rejection. 
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